Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome

Open access

Abstract

Context: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS. Methods: One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four–hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded. Results: As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance. Conclusions: We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-3285

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Schematic of androgen synthesis illustrating the classic androgen pathway (gray boxes) and the steroids of the 11-oxygenated androgen pathway (black boxes). Dotted lines relate distinct steroids to their corresponding urinary steroid metabolite. Abbreviations: 11KDHT, 11-ketodihydrotestosterone; 17OH-PREG, 17α-hydroxypregnenolone; CYB5A, cytochrome b5; CYP11B1, cytochrome P450 11β-hydroxylase; CYP17A1, cytochrome P450 17α-hydroxylase/17,-20-lyase; DHT, 5α-dihydrotestosterone; HSD11B2, 11β-hydroxysteroid dehydrogenase type 2; HSD3B, 3β-hydroxysteroid dehydrogenase; PREG, pregnenolone; SRD5A, steroid 5α-reductase; SULT2A1, sulfotransferase family 2A member 1.
Figure 1. Schematic of androgen synthesis illustrating the classic androgen pathway (gray boxes) and the steroids of the 11-oxygenated androgen pathway (black boxes). Dotted lines relate distinct steroids to their corresponding urinary steroid metabolite. Abbreviations: 11KDHT, 11-ketodihydrotestosterone; 17OH-PREG, 17α-hydroxypregnenolone; CYB5A, cytochrome b5; CYP11B1, cytochrome P450 11β-hydroxylase; CYP17A1, cytochrome P450 17α-hydroxylase/17,-20-lyase; DHT, 5α-dihydrotestosterone; HSD11B2, 11β-hydroxysteroid dehydrogenase type 2; HSD3B, 3β-hydroxysteroid dehydrogenase; PREG, pregnenolone; SRD5A, steroid 5α-reductase; SULT2A1, sulfotransferase family 2A member 1.CC BY · PubMed Central
Figure 2. Serum concentrations of (A, B) classic and (C–F) 11-oxygenated steroids in women with PCOS (n = 114) and healthy sex- and age-matched control subjects (n = 49). (G–I) Major urinary androgen metabolite deriving from the classic androgen pathway, An and etiocholanolone (Et), and the 11β-hydroxyandrostenedione metabolite 11β-OH-An.
Figure 2. Serum concentrations of (A, B) classic and (C–F) 11-oxygenated steroids in women with PCOS (n = 114) and healthy sex- and age-matched control subjects (n = 49). (G–I) Major urinary androgen metabolite deriving from the classic androgen pathway, An and etiocholanolone (Et), and the 11β-hydroxyandrostenedione metabolite 11β-OH-An.CC BY · PubMed Central
Figure 3. Relative contribution (median; %) of the classic androgen pathway (DHEA, A4, T; shades of blue) and the 11-oxygenated C19 steroid pathway (11OHA4, 11KA4, 11OHT, 11KT; shades of red) to the total circulating androgenic steroid pool, comparing patients with PCOS (n = 114) with sex- and age-matched healthy control subjects (n = 49).
Figure 3. Relative contribution (median; %) of the classic androgen pathway (DHEA, A4, T; shades of blue) and the 11-oxygenated C19 steroid pathway (11OHA4, 11KA4, 11OHT, 11KT; shades of red) to the total circulating androgenic steroid pool, comparing patients with PCOS (n = 114) with sex- and age-matched healthy control subjects (n = 49).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 268

Metadata

Authors
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W.
Affiliations
  • University of Birmingham (GB)
  • Stellenbosch University (ZA)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
Corresponding author
Arlt, Wiebke
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2016-11-30
Volume
102
Issue
3
Pages
840-848
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2557976244
Cited by
267
References
36
Citations by year
2026: 26 · 2025: 28 · 2024: 24 · 2023: 23 · 2022: 29 · 2021: 38 · 2020: 36 · 2019: 29 · 2018: 25 · 2017: 8
FWCI
27.48
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (099909, 092283)
  • Newton Fund
  • National Institute for Health and Care Research (ACF-2013-09-001)
  • Royal Society
  • Academy of Medical Sciences (NAF004\1002)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
polycystic ovary syndrome, hyperandrogenism, hyperandrogenemia, 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, 11-ketotestosterone, androgen metabolism, insulin resistance, obesity, testosterone, androstenedione, dehydroepiandrosterone
MeSH terms
Adult, Androgens, Androstenedione, Androstenes, Blood Glucose, Chromatography, Liquid, Dehydroepiandrosterone, Female, Humans, Hydroxytestosterones, Insulin, Insulin Resistance, Gas Chromatography-Mass Spectrometry, Obesity, Polycystic Ovary Syndrome, Testosterone, Case-Control Studies, Hyperandrogenism, Tandem Mass Spectrometry, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1210/jc.2016-3285
The paper
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017). 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2016-3285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.